Zeo ScientifiX, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Zeo ScientifiX, Inc. (ZEOX) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $1.63 million for the 6-month period ending 2026-04-30, per its 10-Q filed 2026-06-15.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-06-15
- Zeo ScientifiX, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-01-31 was $809.00K, a 1184.13% increase year-over-year.
- Zeo ScientifiX, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-01-31 was $63.00K.
- Zeo ScientifiX, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-01-31 was -$584.00K.
- Zeo ScientifiX, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-01-31 was -$2.33M, a 5683.23% decline year-over-year.
- Zeo ScientifiX, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$436.00K.
- Zeo ScientifiX, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$1.10M.
- Zeo ScientifiX, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$2.00M, a 154.79% decline from fiscal 2022.
- Zeo ScientifiX, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $3.64M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | $1.63M 10-Q · filed 2026-06-15 | |||||||
| 2026-01-31 | $809.00K 10-Q · filed 2026-03-17 | |||||||
| 2025-10-31 | -$436.00K 10-K · filed 2026-01-29 | |||||||
| 2025-07-31 | -$343.00K 10-Q · filed 2025-09-15 | |||||||
| 2025-04-30 | -$115.00K 10-Q · filed 2026-06-15 | |||||||
| 2025-01-31 | $63.00K 10-Q · filed 2026-03-17 | |||||||
| 2024-10-31 | -$1.10M 10-K · filed 2026-01-29 | |||||||
| 2024-07-31 | -$651.00K 10-Q · filed 2025-09-15 | |||||||
| 2024-04-30 | -$1.01M 10-Q · filed 2025-06-16 | |||||||
| 2024-01-31 | -$584.00K 10-Q · filed 2025-03-17 | |||||||
| 2023-10-31 | -$2.00M 10-K · filed 2025-01-29 | -$2.00M 10-K · filed 2024-01-29 | ||||||
| 2023-07-31 | -$3.12M 10-Q · filed 2024-09-16 | -$3.12M 10-Q · filed 2023-09-14 | ||||||
| 2023-04-30 | -$2.62M 10-Q · filed 2024-06-14 | -$2.62M 10-Q · filed 2023-06-16 | ||||||
| 2023-01-31 | -$2.33M 10-Q · filed 2024-03-18 | -$2.33M 10-Q · filed 2023-03-17 | ||||||
| 2022-10-31 | $3.64M 10-K · filed 2024-01-29 | |||||||
| 2022-07-31 | -$33.91K 10-Q · filed 2023-09-14 | |||||||
| 2022-04-30 | -$42.57K 10-Q · filed 2023-06-16 | |||||||
| 2022-01-31 | $41.75K 10-Q · filed 2023-03-17 | |||||||
| 2021-10-31 | -$482.23K 10-K · filed 2023-02-14 | |||||||
| 2021-07-31 | -$560.89K 10-Q · filed 2022-09-14 | |||||||
| 2021-04-30 | -$394.88K 10-Q · filed 2022-06-14 | |||||||
| 2021-01-31 | -$523.98K 10-Q · filed 2022-03-16 | |||||||
| 2020-10-31 | $458.24K 10-K · filed 2022-02-14 | |||||||
| 2020-07-31 | $184.39K 10-Q · filed 2021-09-14 |